🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

AMTX AMTX

Company Profile ↓
$1.55
-44.44% 1Y
P/E-1.21
52W High$3.66
52W Low$1.32
EPS (TTM)$-1.28

Company Overview

AMTX (AMTX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 25.1%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 33.4%.

Steady Revenue Expansion

Revenue has grown at a 23.7% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $197.63M (-26.2% YoY); net profit $-77.00M.
  • Trailing 12 Months Year-on-year growth — revenue -26.2%.
  • 5-Year Trend Long-term compounding — revenue CAGR 23.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:23.70%
1 Year:-26.16%

Stock Price Performance

1 Year:-44.44%
6 Months:-8.82%
3 Months:-57.65%
1 Month:-12.43%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 10% of range
$1.32 $3.66
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)45.01 · Neutral
Price Performance
1M-12.43%
3M-57.65%
6M-8.82%
1Y-44.44%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 25.1%.
  • Healthy ROCE of 33.4%.
  • Compounding revenue at 23.7% over 5 years.

CONS

  • Trading 57.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-1.21
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
23.70%
Profit 5Y
-
Revenue (YoY)
-26.16%
Earnings (YoY)
-

Profitability & Returns

ROCE
33.40%
ROE
25.10%
ROA
-29.63%
Profit Margin
-38.96%
Op Margin
-18.83%
Gross Margin
-0.39%
EPS (Latest Qtr)
$-0.33
EPS (TTM)
$-1.28

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$270.33M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
7.13%
Chg in Prom Hold
-
FII / Inst Holding
19.27%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$197.63M
EBITDA
-
Free Cash Flow
$-22.74M
Operating Cash Flow
$3.26M
Shares Outstanding
-
Gross Margin
-0.39%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------------31.57M40.76M38.94M43.02M45.03M44.63M41.89M50.62M57.39M39.48M47.82M40.92M42.81M54.88M49.90M52.05M65.90M-----------
Gross Profit 11.26M15.62M11.35M7.71M2.45M-228.00K1.03M1.03M1.44M2.09M1.94M3.67M-587.00K1.71M1.96M1.87M2.77M2.67M-351.00K3.27M3.98M-433.00K14.06M771.00K-3.61M3.65M-4.79M-3.08M-214.00K-1.10M-1.29M1.96M492.00K-612.00K-1.81M3.88M-5.08M-3.35M-58.00K2.76M
Operating Income 7.99M12.68M7.76M4.64M-997.00K-3.97M-1.86M-1.86M-1.48M-1.01M-1.06M357.00K-3.97M-1.67M-3.10M-2.00M-876.00K-1.30M-4.62M-762.00K-584.00K-4.49M9.99M-3.83M-9.01M-2.13M-9.89M-10.43M-7.69M-7.59M-12.12M-7.79M-8.53M-9.46M-13.61M-3.87M-15.55M-10.67M-8.51M-6.33M
Net Income 3.26M7.69M2.72M464.00K-3.74M-8.64M-5.75M-5.75M-6.45M-5.11M-4.98M-4.09M-8.53M-5.99M--11.11M-6.22M-6.65M-10.67M-13.93M-7.23M-12.05M2.19M-12.22M-18.11M-10.56M-17.60M-18.29M-209.00K-66.84M-26.41M-25.28M30.71M-24.23M-29.17M-17.93M-24.53M-23.39M-23.75M-21.71M
Diluted EPS -0.340.130.02--0.42-0.29-0.29--0.26-0.25-0.21-0.43-0.30-0.38-0.51-0.27-0.29-0.48-0.63-0.31-0.580.10-0.59-0.69-0.34-0.55-0.54-0.01-1.92-0.73-0.680.73-0.58-0.66-0.38-0.47-0.41-0.37-0.33
R&D Expense 71.00K100.00K141.00K101.00K117.00K109.00K117.00K117.00K117.00K97.00K106.00K87.00K86.00K110.00K1.88M62.00K55.00K74.00K33.00K90.00K37.00K117.00K21.00K37.00K23.00K21.00K22.00K36.00K51.00K52.00K42.00K37.00K36.00K-------

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 8.13M141.86M189.05M177.51M207.68M146.65M143.16M150.16M171.53M202.00M165.56M211.95M28.11M77.19M267.64M197.63M
Gross Profit -122.02K4.64M-8.93M18.29M37.14M4.20M11.60M3.38M5.41M12.70M11.03M7.94M-5.54M2.02M-580.00K-768.00K
Operating Income -5.15M-4.51M-21.16M2.48M24.09M-8.61M-781.00K-12.18M-10.93M-4.93M-6.07M-15.82M-34.40M-37.40M-40.42M-37.22M
Net Income -8.56M-18.30M-4.28M-24.44M7.13M-27.14M-15.64M-31.77M-36.29M-39.48M-36.66M-47.15M-107.76M-46.42M-87.54M-77.00M
Diluted EPS ---0.28-1.280.34-1.37-0.79-1.53-1.63-1.75-1.74-1.54-3.12-1.22-1.91-1.28
R&D Expense 322.56K576.62K620.00K539.00K459.00K447.00K369.00K2.37M246.00K205.00K213.00K88.00K180.00K152.00K--

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -21.59M27.22M96.87M97.14M89.18M83.14M77.81M94.33M91.82M99.89M125.14M160.83M207.11M243.41M259.30M259.84M
Total Equity -3.69M-9.45M-22.20M3.51M-12.77M-2.97M-35.29M-49.81M-78.39M-115.58M-154.37M-184.74M-120.24M-201.85M-216.98M-263.93M-306.83M
Cash & Equivalents 52.18K683.02K249.00K291.00K4.93M332.00K283.00K1.49M428.00K1.19M656.00K592.00K7.75M4.31M2.67M898.00K4.89M
Long Term Debt --19.99M25.95M73.79M64.56M88.95M100.31M138.16M157.82M179.69M170.10M165.99M197.02M257.69M247.53M63.90M
Current Liabilities -18.30M29.43M57.84M36.12M27.32M29.30M27.22M36.02M42.58M57.82M102.23M65.33M88.28M84.39M143.97M371.26M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -3.68M-1.25M-16.93M-1.68M20.59M-786.00K371.00K-8.69M-5.51M-2.03M2.48M-20.65M-22.87M13.82M-32.93M3.26M
Investing Cash Flow -672.97K-967.96K-16.46M224.00K-1.97M-71.00K-629.00K-1.12M-4.07M-8.58M-17.31M-22.89M-31.31M-23.69M-14.15M-25.59M
Financing Cash Flow 4.86M1.87M33.34M6.25M-23.23M816.00K1.63M8.38M10.39M10.09M14.78M50.70M53.63M9.09M44.62M26.41M
Capital Expenditure -672.97K-2.57M-1.37M-1.28M-1.97M-71.00K-629.00K-1.12M-4.07M-8.58M-19.34M-26.65M-39.16M-33.12M-20.25M-26.00M
Free Cash Flow -4.36M-3.81M-18.30M-2.96M18.63M-857.00K-258.00K-9.80M-9.58M-10.61M-16.86M-47.30M-62.02M-19.29M-53.18M-22.74M
Share Buybacks -----7.48M0---------

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -1.5%3.3%-4.7%10.3%17.9%2.9%8.1%2.2%3.2%6.3%6.7%3.7%-19.7%2.6%-0.2%-0.4%
Operating Margin % -63.4%-3.2%-11.2%1.4%11.6%-5.9%-0.5%-8.1%-6.4%-2.4%-3.7%-7.5%-122.4%-48.5%-15.1%-18.8%
Net Margin % -105.3%-12.9%-2.3%-13.8%3.4%-18.5%-10.9%-21.2%-21.2%-19.5%-22.1%-22.2%-383.3%-60.1%-32.7%-39.0%
ROE % 90.6%82.4%-121.9%191.4%-240.0%76.9%31.4%40.5%31.4%25.6%19.8%39.2%53.4%21.4%33.2%25.1%
ROCE % -156.5%203.8%-54.2%4.1%38.9%-16.0%-1.5%-20.9%-22.2%-11.7%-26.5%-16.6%-28.9%-23.5%-35.0%33.4%

Shareholding Pattern

Insiders
7.13%
Institutions
19.27%
Public Float
20.75%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AMTX

Google News ue, 04 Aug 2026

India Targets 5% Biodiesel Blending as Aemetis Supplies 18M Liters - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNemRqQ3UzZWU0RzZBdUZUenBGaUZUZ0paVXVGXzFmQ1pVMFh5bVpUOTdfT3FRWG9jRXNJbVlSczZXLWwzc0pSOEhRWUhUR1JrN1ZVZTRMZGVhb3Uwdmp3cVhUMmZPWGlQbzhLYzFWVmNFbUlhZzgxSDN5OGFPNF9LWlphZE1la2tFam91U2…

Google News Wed, 22 Jul 2026

$AMTX stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQd3R6eFZxaExYMkFhQlNvN2tXYjlpV3hwVDRubVhOX2VsQnlrbFo2bDNTVXFZamJvNTlzbUZBNmpBaDc3ZHdEdlZ4ajdLOFowRVNKMGp3WUFaZGVyZHVrbjk0b3lsZTV5LUdTdENZcEprZnJ1OU1ZOEViWmxFdlZCeG1DQl9VUGlrOWcwV2…

Google News ue, 09 Jun 2026

When Can We Expect A Profit From Aemetis, Inc. (NASDAQ:AMTX)? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQXzRQSmhEeGtTd0J2eXQ3dVA5LTlsOVpPTjBpVGNybVZSUkpDZi01bDZiM1gyanJKVDB5NkhpSDJDWjFxVjllQ183SF8waTZPX01qVXlLQllmNVppV0d5Z1VEQjlSeXZhN0VSbm1KNGRISnlJUUJnbU9KYVdCMDA2RkZ0cFMyWk5CUS15SX…

Google News ue, 04 Aug 2026

Aemetis stock rises on India biodiesel supply deal - Investing.com

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQMnMtTk1Ca3JWemtYalVrS0hZMVFYR0hlZ0FoT21lLUtteGJ6MEdCUEx6X1JaSDdQOWVMejNSYW0tVFhwWG1GRVFCU2hIS0JKYU9YRXBPdS0yNlFQWExla3BvM3ZsSkpEaEM4QlRKUWNJaEZoSFFBaHhaVkZabGx6VzRwM09tdVlWX2VEVX…

Google News Sat, 27 Jun 2026

Aemetis, Inc. Actuals & Estimates (NASDAQ:AMTX) - TradingView

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPYXdaN3habFRCWi1Vb2lFU0Mtbi1VbDVBbzRlN2x5OWIyVU5lVndKRHNZMS1PYTlXSXhmOGpyNHdPa1hEcF95SXVPVHVYN3JPd1pVZTlHQnl1Z3dtZnhRSGo4QUEzbnE1aFpYa0MxSVEycFdOQV90MENubW1NOWlzcUlyM2g4UQ?oc=5" t…

Google News Fri, 17 Jul 2026

Aemetis (NASDAQ:AMTX) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened - MarketBeat

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQdkhsdjRDc2tIdWRtZVZVMW13Q1dzdjM1TEVpMDNtRS1sMXR6ZEU5V3AwQ3NzcGNUd1V4N3VzVXU2Q2NRczRSdGNsR0lVaG9CZnV5RmRVYnZsOUR6eWQ2YU5wdkdWcUJCUkZ4SDVfS1RyMG5lTjJhVHhRRDhqUnNCN19scVl5VFRzVnJkYj…

AMTX — Frequently Asked Questions

What is the current share price of AMTX?

As of 2026-08-05 17:25 PDT, AMTX trades at $1.55 on NASDAQ/NYSE. Its 52-week range is $1.32 to $3.66.

What is the P/E ratio of AMTX?

AMTX trades at a trailing price-to-earnings (P/E) ratio of -1.21.

What is the return on equity (ROE) of AMTX?

AMTX has a return on equity (ROE) of 25.10%. Its return on capital employed (ROCE) is 33.40%.

Is AMTX a good stock to buy?

This page provides a data-driven analysis of AMTX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space